Discovery May Lead To New Approaches To Cancer, Neurodegeneration, Growth Defects And Diabetes
11/13/2011
Cells develop and thrive by turning genes on and off as needed in a precise pattern, a process known as regulated gene transcription...
Hemacord - First Cord Blood Product Approved By FDA
11/12/2011
The FDA has approved HEMACORD, the first cord blood product ever to be approved in the USA. It used in hematopoietic stem cell transplantation procedures for individuals with disorders affecting the blood-forming system - known as the hematopoietic system. Potential patients include those with some kinds of blood cancers, as well as people with inherited metabolic and immune system disorders...
FDA Approves New York Blood Center's HEMACORD™ For Stem Cell Transplantation
11/12/2011
The Food and Drug Administration has licensed HEMACORD™ (Hematopoietic Progenitor Cells-Cord, HPC-C) for allogeneic hematopoietic (blood-forming) stem cell transplantation, the first such approval of a stem cell product in the world...
Predicting Cellular Response To Paclitaxel In Epithelial Ovarian Cancer
11/12/2011
New research findings by UCD scientists published online today in the Journal of Pathology may help clinicians predict how patients with high grade, serous, epithelial ovarian cancer will respond to paclitaxel chemotherapy (Taxol®)...
High Fiber Diet Reduces Colorectal Cancer Risk
11/12/2011
A new study published on bmj.com demonstrates that eating high- fiber diet, particularly cereal and whole grains, is linked to a reduced risk of colorectal cancer. Worldwide, colorectal cancer is the third most common cancer, with 1.2 million new cases diagnosed every year...
New Approaches To The Treatment Of Early-stage Liver Cancer
11/12/2011
Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan...
Fibre, Whole Grains, Linked To Lower Colorectal Cancer Risk
11/11/2011
Following a diet high in fibre, particularly from whole grains and cereals like brown rice and oats, is linked to a lower risk of colorectal cancer, according to researchers in Britain and The Netherlands who pooled all available published evidence, covering nearly 2 million people. They write about their findings in a study published online in the BMJ on 10 November...
FDA Approves Cord Blood For Stem Cell Transplant
11/11/2011
The US Food and Drug Administration (FDA) has approved the first product to use umbilical cord blood for stem cell transplantation. In a news release on Thursday, the agency said it has approved Hemacord, developed by the New York Blood Center, as "the first licensed hematopoietic progenitor cells-cord (HPC-C) cell therapy"...
Drug That Attacks Blood Supply Of Fat Cells Causes Weight Loss In Obese Monkeys
11/11/2011
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine...
Fecal Occult Blood Testing Effective In Colonoscopy Screenings
11/11/2011
Fecal immunochemical testing (FIT) is more effective in its health benefits at the same or lower costs compared to guaiac fecal occult blood testing (gFOBT) at all levels of colonoscopy capacity, according to a study published by the Journal of the National Cancer Institute. In many countries, wait times for colonoscopy screenings can take up to 12 weeks...